- Title
- Aspirin and NSAID use and lung cancer risk: a pooled analysis in the International Lung Cancer Consortium (ILCCO)
- Creators
- Valerie A McCormack - Section of Environment and Radiation, International Agency for Research on Cancer, 150 cours Albert Thomas, 69008 Lyon, FranceRayjean J Hung - Samuel Lunenfeld Research Institute of Mount Sinai Hospital, Toronto, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, CanadaDarren R Brenner - Samuel Lunenfeld Research Institute of Mount Sinai Hospital, Toronto, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, CanadaHeike Bickeboller - Department of Genetic Epidemiology Medical School, Georg-August-University of Gottingen, Gottingen, GermanyAlbert Rosenberger - Department of Genetic Epidemiology Medical School, Georg-August-University of Gottingen, Gottingen, GermanyJoshua E Muscat - Pennsylvania State Cancer Institute, Pennsylvania State College of Medicine, Hersey, PA, USAPhilip Lazarus - Pennsylvania State Cancer Institute, Pennsylvania State College of Medicine, Hersey, PA, USAAnne Tjønneland - Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, DenmarkSøren Friis - Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, DenmarkDavid C Christiani - Harvard School of Public Health, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USAEun-mi Chun - Harvard School of Public Health, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USALoic Le Marchand - Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HI, USAGad Rennert - Department of Community Medicine and Epidemiology, Carmel Medical Center and Bruce Rappaport Faculty of Medicine, Israel Institute of Technology and Clalit Health Services National Cancer Control Center, Haifa, IsraelHedy S Rennert - Department of Community Medicine and Epidemiology, Carmel Medical Center and Bruce Rappaport Faculty of Medicine, Israel Institute of Technology and Clalit Health Services National Cancer Control Center, Haifa, IsraelAngeline S Andrew - Norris Cotton Cancer Center, Department of Community & Family Medicine, Dartmouth Medical School, Lebanon, NH, USAIrene Orlow - Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USABernard Park - Hackensack University Medical Center, Hackensack, NJ, USAPaolo Boffetta - Tisch Cancer Institute and Institute for Translational Epidemiology, Mount Sinai School of Medicine, New York, NY, USA; International Prevention Research Institute, Lyon, FranceEric J Duell - Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain
- Publication Details
- Cancer causes & control, Vol.22(12), pp.1709-1720
- Academic Unit
- Pharmaceutical Sciences, Department of
- Grant note
- P20 RR018787 || RR / National Center for Research Resources : NCRR
- Identifiers
- 99900547594101842
- Language
- English
- Resource Type
- Journal article
Journal article
Aspirin and NSAID use and lung cancer risk: a pooled analysis in the International Lung Cancer Consortium (ILCCO)
Cancer causes & control, Vol.22(12), pp.1709-1720
12/2011
Handle:
https://hdl.handle.net/2376/111751
PMCID: PMC3852431
PMID: 21987079
Abstract
Metrics
19 Record Views